1. Home
  2. Disease & Disorders
  3. San Diego, CA
  4. Curebound

Curebound

Curebound has an America's Best Score of 52 out of 100, based on its 2025 Form 990, below the 60-point bar to be ranked.

  • San Diego, CA
  • Tax-exempt since 2014
  • EIN: 46-0552414
curebound.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
52OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Curebound is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G123). Contributions are tax-deductible.

9605 Scranton Rd Ste 120, San Diego, CA 92121-1767

Among the 24 scored disease & disorders organizations in San Diego, Curebound holds 7.3 months of operating reserves (peer median 13.8 months), runs a typical yearly deficit of 21.5% (peers: surplus of 0.9%), and has grown spending 33.6% a year (peers: grown spending 3.8% a year).

In fiscal year 2025 it reported $10,968,237 in revenue and $14,851,654 in expenses, with contributions making up 72.7% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

Curebound's mission is to accelerate cancer research and save lives. We raise and invest strategic funding for innovative adult and pediatric cancer research with one vision: Cures in our lifetime.

Main program · fiscal year 2025

  • Curebound is a community-powered cancer research accelerator with a unique funding model built on a core belief that the best ideas happen when the right people work together. We unite top scientists, passionate advocates, entrepreneurs and investors to advance cancer research that has the greatest opportunity to improve detection, treatment, and survivorship. All Curebound grants demand scientifi… Read more

    Curebound is a community-powered cancer research accelerator with a unique funding model built on a core belief that the best ideas happen when the right people work together. We unite top scientists, passionate advocates, entrepreneurs and investors to advance cancer research that has the greatest opportunity to improve detection, treatment, and survivorship. All Curebound grants demand scientific collaboration across institutions to drive results for patients who need it now. Through rigorous review and transparency, we direct every investment dollar towards meaningful impact. Representative research partner institutions include (but not limited to): Uc San Diego moores cancer center, the salk institute, sanford-burnham prebys medical discovery institute, rady children's hospital, scripps research, and la jolla institute of immunology.headquartered in San Diego, one of the nation's premier hubs for cancer research and life-science innovation, Curebound catalyzes complementary strengths across biology, technology, data science, and clinical networks to accelerate the translation of discovery into clinical impact. Curebound allocates and administers research funding through five grant mechanisms spanning discovery through clinical translation: Discovery, targeted, catalyst, equity, cure prize. Each of these grant types aligns to Curebound's overarching and research roadmap with clearly defined timelines and measurable milestones that are tracked to accelerate progress.

    $11,714,338 spent

Where each dollar went · fiscal year 2025

Of every dollar it spent, 79¢ went to programs, 11¢ to management and 10¢ to fundraising.

  • Programs $11,714,338
  • Management $1,688,385
  • Fundraising $1,448,931

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score52 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves7.3 mo; 5.9 mo in cash5.1 / 25
Financial balance (median margin)−21.5%0 / 20
Transparency5 full 990s, latest TY202520 / 20
Program growth+33.6% / yr15 / 15
Track record12 years4.8 / 10
Debt load23.8% of assets7.2 / 10
Total52.1 → 52
Spending on programs
Not scored; America's Best needs 65%+
79%Meets

Compared with San Diego peers

MeasureThis organizationPeer median
Operating reserves7.3 mo13.8 mo
Typical margin−21.5%+0.9%
Spending growth+33.6% / yr+3.8% / yr
Debt load23.8%12.4%

Peers: the 24 San Diego disease & disorders organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$10,968,237Fiscal year 20252021: $8,784,43120212022: $19,804,41320222023: $10,395,52820232024: $5,488,90120242025: $10,968,2372025
Expenses$14,851,654Fiscal year 20252021: $2,833,60520212022: $6,229,06920222023: $12,500,34220232024: $10,744,44320242025: $14,851,6542025
Total assets$11,857,815Fiscal year 20252021: $7,606,27420212022: $23,579,08320222023: $24,388,12320232024: $16,440,88320242025: $11,857,8152025
Total liabilities$2,822,688Fiscal year 20252021: $898,95920212022: $3,295,06220222023: $6,208,91620232024: $3,522,33920242025: $2,822,6882025
Fiscal year ending December 2025
Revenue$10,968,237
Expenses$14,851,654
Net income−$3,883,417
Net assets$9,035,127

Notable sources of revenue

Percent of total revenue
Contributions$7,968,991
Program services$0
Investment income$343,112
Other (net)$2,656,134

Assets / debt

Total assets$11,857,815
Total liabilities$2,822,688
Net assets$9,035,127

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$5,488,901
Expenses$10,744,443
Net income−$5,255,542
Net assets$12,918,544

Notable sources of revenue

Percent of total revenue
Contributions$5,672,165
Program services$0
Investment income$522,299
Other (net)−$705,563

Assets / debt

Total assets$16,440,883
Total liabilities$3,522,339
Net assets$12,918,544

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$10,395,528
Expenses$12,500,342
Net income−$2,104,814
Net assets$18,179,207

Notable sources of revenue

Percent of total revenue
Contributions$7,931,168
Program services$0
Investment income$246,733
Other (net)$2,217,627

Assets / debt

Total assets$24,388,123
Total liabilities$6,208,916
Net assets$18,179,207

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$19,804,413
Expenses$6,229,069
Net income$13,575,344
Net assets$20,284,021

Notable sources of revenue

Percent of total revenue
Contributions$18,221,209
Program services$2,931,116
Investment income$48
Other (net)−$1,347,960

Assets / debt

Total assets$23,579,083
Total liabilities$3,295,062
Net assets$20,284,021

Compensation

Officers and key employees$523,693
Share of expenses8.4%
Fiscal year ending December 2021
Revenue$8,784,431
Expenses$2,833,605
Net income$5,950,826
Net assets$6,707,315

Notable sources of revenue

Percent of total revenue
Contributions$8,750,114
Program services$76,935
Investment income$13
Other (net)−$42,631

Assets / debt

Total assets$7,606,274
Total liabilities$898,959
Net assets$6,707,315

Compensation

Not in our extract for this year.

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?